台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    83.1
  • 漲跌
    ▲2.3
  • 漲幅
    +2.85%
  • 成交量
    221
  • 產業
    上櫃 生技醫療類股
  • 119人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
訊聯 (1784)籌碼相關-國泰-台南 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

國泰-台南 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/22082.7000.0083.1004370.00%
2025/01/1600.000.182.2082.20-0.1455-0.01%
2025/01/14082.6000.0084.1004600.00%
2025/01/09083.5000.0082.5004660.00%
2024/12/2600.00081.8080.9005250.00%
2024/12/250.180.050.180.0080.3005210.00%
2024/12/20079.3000.0079.1005440.00%
2024/12/190.179.7400.0079.500.15470.01%
2024/12/18082.5000.0082.4005480.00%
2024/12/170.283.4000.0083.400.25820.03%
2024/12/16284.15183.4082.0015980.17%
2024/12/13090.8000.0087.2005870.00%
2024/12/122.293.19196.7092.601.25800.21%
2024/12/11198.0000.0097.6015680.18%
2024/12/0410100.7015100.10100.50-5550-0.91%
2024/12/03096.8000.0095.7005210.00%
2024/12/02296.75296.2096.5005230.00%
2024/11/29096.8000.0097.0005190.00%
2024/11/2500.000.397.8097.40-0.3565-0.05%
2024/11/21295.55294.6593.3005840.00%
2024/11/20296.00196.0095.9015650.18%
2024/11/180.187.3000.0088.700.16270.02%
2024/11/11192.60192.1092.6006730.00%
2024/11/0800.001092.3094.10-10711-1.41%
2024/11/0700.00592.5092.60-5716-0.70%
2024/11/06191.2000.0091.5017290.14%
2024/11/040.290.9000.0090.800.27910.03%
2024/10/25194.5000.0094.8019270.11%
2024/10/230.1100.001.199.9599.80-11,012-0.10%
2024/10/17094.7000.0094.2001,5350.00%
2024/10/11093.4000.0090.9001,5710.00%
2024/10/09096.0000.0096.1001,5850.00%
2024/10/07099.7000.0099.4001,6420.00%
2024/10/0400.001098.2098.80-101,685-0.59%
2024/09/3030104.8300.00100.00301,7061.76%
2024/09/25198.4000.0097.6012,0660.05%
2024/09/24599.361396.9896.60-82,246-0.36%
2024/09/2300.004100.00100.00-42,243-0.18%
2024/09/200102.5000.00101.0002,2780.00%
2024/09/1917.1105.555103.60102.5012.12,2880.53%
2024/09/1800.006.6116.50116.50-6.62,273-0.29%
2024/09/1600.000105.00106.0002,2980.00%
2024/09/120.2103.8700.00104.000.22,3690.01%
2024/09/0900.000103.50105.5002,4990.00%
2024/09/060.1106.5000.00105.500.12,5510.00%
2024/09/043107.835.1109.81109.00-2.12,594-0.08%
2024/09/034.2115.102118.00113.502.22,6340.08%
2024/09/020.1116.501116.50116.50-0.92,691-0.03%
2024/08/305117.2000.00116.5052,7630.18%
2024/08/294120.132.1119.33118.001.92,8210.07%
2024/08/281119.0000.00119.0012,8880.03%
2024/08/273.1121.084121.00122.00-0.92,958-0.03%
2024/08/261120.501121.49120.5002,9860.00%
2024/08/231.1114.501115.50115.000.13,0100.00%
2024/08/224115.632114.50114.5023,0030.07%
2024/08/214116.633115.67117.0012,9980.03%
2024/08/201116.500122.50116.0012,9730.03%
2024/08/190112.0000.00111.5002,9260.00%
2024/08/160.2112.002112.50113.00-1.92,933-0.06%
2024/08/1400.0010111.40112.00-102,956-0.34%
2024/08/1314110.184110.88113.50102,9810.34%
2024/08/123.1114.342114.75112.001.12,9620.04%
2024/08/090.1107.502109.00107.50-22,926-0.07%
2024/08/072108.502.2105.73108.50-0.22,906-0.01%
2024/08/06199.10399.40103.00-22,890-0.07%
2024/08/051100.001103.5099.5002,8530.00%
2024/08/011120.001121.00117.0002,8020.00%
2024/07/3000.002.2115.72116.50-2.22,779-0.08%
2024/07/291116.001114.00113.5002,7480.00%
2024/07/261125.0011126.00126.00-102,692-0.37%
2024/07/235136.609.2132.05132.00-4.22,666-0.16%
2024/07/2215.1141.3517.2140.17136.00-2.12,647-0.08%
2024/07/1954.4165.5542151.11145.5012.42,5720.48%
2024/07/1830.3157.2227.1159.47161.503.32,3020.14%
2024/07/171146.931144.00147.0002,2110.00%
2024/07/162141.751144.00141.5012,1980.05%
2024/07/151145.0000.00143.5012,1960.05%
2024/07/1200.0015140.53139.00-152,177-0.69%
2024/07/112144.751142.50140.0012,1630.05%
2024/07/1000.004145.63147.50-42,144-0.19%
2024/07/094147.501152.00143.5032,1300.14%
2024/07/081145.507.2143.43146.00-6.22,083-0.30%
2024/07/051135.0000.00133.0012,0390.05%
2024/07/044130.132131.00135.5022,0270.10%
2024/07/0315136.0711135.41133.0042,0080.20%
2024/07/0237.2136.6029.1135.04140.008.21,9350.42%
2024/07/013.2133.745134.90139.50-1.81,729-0.10%
2024/06/2831122.0214125.54127.00171,6231.05%
2024/06/2600.001098.00105.00-101,428-0.70%
2024/06/24195.5000.0094.2011,3710.07%
2024/06/211097.1000.0093.70101,3510.74%
2024/06/20197.102099.0099.40-191,308-1.45%
2024/06/192098.60396.9394.20171,2791.33%
2024/06/18696.62397.4096.1031,2420.24%
2024/06/17194.80193.9091.5001,1950.00%
2024/06/1400.00186.5087.70-11,153-0.09%
2024/06/13287.501087.5985.30-81,125-0.71%
2024/06/12784.66983.4083.40-21,069-0.19%
2024/06/11283.401684.5982.80-141,051-1.33%
2024/06/071083.75484.4083.0061,0170.59%
2024/06/060.181.90184.5081.20-1969-0.10%
2024/06/05383.53484.1587.00-1907-0.11%
2024/06/041983.5213.185.7180.005.98360.70%
2024/06/0315.185.10685.3785.009.17731.18%
2024/05/312080.351781.3082.4036900.43%
2024/05/302177.441977.2477.3026070.33%
2024/05/29174.00172.7074.0005470.00%
2024/05/2300.000.169.2067.20-0.1496-0.02%
2024/05/2100.00270.6070.00-2479-0.42%
2024/05/200.172.2000.0071.700.14710.02%
2024/05/17268.90269.7569.9004540.00%
2024/05/16166.4000.0066.2014220.24%
2024/05/15466.98466.3066.7004190.00%
2024/05/0700.00064.6065.9004020.00%
2024/05/061067.621266.6466.70-2396-0.50%
2024/05/03165.8000.0065.9013850.26%
2024/05/02966.089.167.1466.50-0.1380-0.03%
2024/04/30065.2000.0064.2003620.00%
2024/04/29666.10665.7065.1003620.00%
2024/04/261068.46967.9366.4013550.28%
2024/04/25466.08262.9069.4023090.65%
2024/04/23162.30262.8064.10-1288-0.35%
2024/04/22362.17360.8060.8002780.00%
2024/04/19158.50060.7058.8012810.35%
2024/04/1800.00061.5561.3002760.00%
2024/04/17064.7500.0061.8002800.00%
2024/04/1600.00062.6061.4002810.00%
2024/04/15065.9000.0063.6002780.00%
2024/04/12064.5000.0064.0002760.00%
2024/04/090.166.5000.0065.900.12720.04%
2024/04/03164.10164.4064.5002620.00%
2024/04/0200.00165.3065.30-1257-0.39%
2024/03/25064.90164.2063.40-1252-0.40%
2024/03/22464.48364.7064.2012560.39%
2024/03/21264.75164.5064.4012580.39%
2024/03/19064.8000.0063.8002400.00%
2024/03/08062.40160.8061.10-1231-0.43%
2024/02/22061.5000.0061.8002220.00%
2024/02/19061.3000.0060.4002020.00%
2024/01/30158.5000.0058.3012130.47%
訊聯2024年外泌體與幹細胞趨勢論壇 聚焦羊水與臍帶血應用Anue鉅亨-2024/12/25
訊聯H1外泌體業績年增1.8倍 旗下訊聯細胞智藥擬Q4登興櫃Anue鉅亨-2024/08/26
訊聯 相關文章
訊聯 相關影音